Mulmit

ENANTA PHARMACEUTICALS INCENANTA PHARMACEUTICALS INC

ENTA Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-09-3065,324,000-85,349,000-81,889,000-3.84
2024-09-3067,635,000-121,691,000-116,045,000-5.48
2023-09-3079,204,000-137,207,000-133,816,000-6.38
2022-09-3086,160,000-123,844,000-121,755,000-5.91
2021-09-3097,074,000-109,573,000-78,996,000-3.92

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-08Rottinghaus Scott T.Chief Medical Officer1,467
2026-03-11Vance Terry20,000
2026-03-11Russell Lesley20,000
2026-03-11Peterson Kristine20,000
2026-03-11Hata Yujiro S20,000
2026-03-11FOLETTA MARK G20,000
2026-03-11CARTER BRUCE L A20,000
2026-02-12Kowalsky Matthew PaulChief Legal Officer1,318
2026-02-12Kowalsky Matthew PaulChief Legal Officer4,175
2026-02-12Kowalsky Matthew PaulChief Legal Officer1,902
2026-02-12Luu BrendanChief Business Officer1,575
2026-02-12Luu BrendanChief Business Officer4,987

8-K events

FiledItems
2026-08-10Results of operations · Financial statements and exhibits
2026-07-02Entry into a material agreement · Financial statements and exhibits
2026-06-23Other events
2026-06-18Regulation FD disclosure · Financial statements and exhibits
2026-05-11Results of operations · Financial statements and exhibits
2026-03-26Other events
2026-03-12Officer or director change · Submission of matters to a vote · Financial statements and exhibits
2026-02-09Results of operations · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.